Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles C. Koch S. Hahn S. Evans Original Article Pages: 177 - 187
Synergistic interaction between topotecan and microtubule-interfering agents Hamid R. BahadoriMark R. GreenCarlo V. Catapano Original Article Pages: 188 - 196
Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver Ricky A. SharmaMartin M. EatockWilliam P. Steward Original Article Pages: 197 - 201
Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs Jeffrey G. SupkoRocio Garcia-CarboneroLouis Malspeis Original Article Pages: 202 - 208
Hepatic arterial and intravenous administration of 1,25-dihydroxyvitamin D3 – evidence of a clinically significant hepatic first-pass effect I. Finlay G. Stewart D. Morris Original Article Pages: 209 - 214
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients Rebecca R. ThomasWilliam DahutChris H. Takimoto Original Article Pages: 215 - 222
Bioavailablility of penclomedine and systemic exposure to 4-O-demethylpenclomedine in patients receiving oral and intravenous penclomedine Seamus O'ReillyNeil R. HartmanJohn M. Strong Original Article Pages: 223 - 228
Carboplatin and paclitaxel interact antagonistically in a megakaryoblast cell line – a potential mechanism for paclitaxel-mediated sparing of carboplatin-induced thrombocytopenia Alexander D. GuminskiPaul R. HarnettAnna deFazio Original Article Pages: 229 - 234
Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates Wanda SalzerBrigitte WidemannFrank M. Balis Original Article Pages: 235 - 240
Limited sampling models for CPT-11, SN-38, and SN-38 glucuronide Jeff A. SloanPamela AthertonLarry Schaaf Original Article Pages: 241 - 249
Therapeutic activity of the topoisomerase I inhibitor J-107088 [6-N-(1-hydroxymethyla-2-hydroxy) ethylamino-12,13-dihydro-13-(β-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolo[3,4-c]-carbazole-5,7(6H)-dione] against pediatric and adult central nervous system tumor xenografts Christina M. CavazosStephen T. KeirHenry S. Friedman Original Article Pages: 250 - 254
Cisplatin and escalating doses of paclitaxel and epirubicin in advanced ovarian cancer. A phase I study Mario NardiSalvatore De MarcoFrancesco Cognetti Original Article Pages: 255 - 258